SeaStar Medical Holding Corp (ICU)

SeaStar Medical Holding Corp experienced three recent insider trading transactions, all representing purchases. Executives, including the Chief Financial Officer and Chief Medical Officer, acquired shares totaling approximately $10,838. This activity follows a period where the stock price declined significantly, despite the company reporting a miss in its latest earnings report.
Ticker: ICU Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SeaStar Medical Holding Corp. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.7
Messinger Michael Chief Financial Officer Officer
Transaction date
Purchase
Price
493.90
Quantity 76,621 +26.4%
Value US$4,266,852
1.7
Messinger Michael Chief Financial Officer Officer
Transaction date
Purchase
Price
389.95
Quantity 15,117 +41.5%
Value US$330,609
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
255.00
Quantity 56,406 +12.5%
Value US$3,687,813
1.7
Messinger Michael Chief Financial Officer Officer
Transaction date
Purchase
Price
3.27
Quantity 750 +42.9%
Value US$2,452
1.8
Baird Jennifer A Non-Executive Director
Transaction date
Purchase
Price
0.24
Quantity 4,200 +13.1%
Value US$987
1.7
Messinger Michael Chief Financial Officer Officer
Transaction date
Purchase
Price
0.35
Quantity 14,500 +483.3%
Value US$5,098
2.9
Van Heel Kenneth Non-Executive Director
Transaction date
Purchase
Price
0.86
Quantity 10,000 +25.4%
Value US$8,565
2.9
Van Heel Kenneth Non-Executive Director
Transaction date
Purchase
Price
0.89
Quantity 25,000 +173.6%
Value US$22,248
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
0.80
Quantity 10,000 +20.8%
Value US$8,000
1.8
Baird Jennifer A Non-Executive Director
Transaction date
Purchase
Price
0.42
Quantity 10,000 +55.6%
Value US$4,174
3.0
Neuman John Non-Executive Director
Transaction date
Purchase
Price
0.36
Quantity 40,000 +100.0%
Value US$14,396
1.8
Baird Jennifer A Non-Executive Director
Transaction date
Purchase
Price
1.28
Quantity 10,000 New position
Value US$12,815
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
1.25
Quantity 4,500 +32.9%
Value US$5,625
3.0
Neuman John Non-Executive Director
Transaction date
Purchase
Price
2.04
Quantity 10,000 +33.3%
Value US$20,405
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
1.99
Quantity 4,250 +45.0%
Value US$8,458
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
4.26
Quantity 1,000 +11.9%
Value US$4,258
3.0
Neuman John Non-Executive Director
Transaction date
Purchase
Price
5.24
Quantity 10,000 +50.0%
Value US$52,396
3.0
Neuman John Non-Executive Director
Transaction date
Purchase
Price
4.35
Quantity 10,000 +100.0%
Value US$43,521
3.0
Neuman John Non-Executive Director
Transaction date
Purchase
Price
3.69
Quantity 10,000 New position
Value US$36,905
2.9
Van Heel Kenneth Non-Executive Director
Transaction date
Purchase
Price
0.40
Quantity 100,000 +609.8%
Value US$40,000
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
0.48
Quantity 1,150 +1.7%
Value US$546
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
0.48
Quantity 2,300 +3.6%
Value US$1,092
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
0.48
Quantity 4,000 +6.6%
Value US$1,920
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
0.47
Quantity 5,093 +9.2%
Value US$2,394
0.8
Russell Richard D. Non-Executive Director
Transaction date
Purchase
Price
0.50
Quantity 20,000 +250.7%
Value US$10,000
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
0.70
Quantity 7,500 +15.6%
Value US$5,248
2.0
Chung Kevin Chief Medical Officer Officer
Transaction date
Purchase
Price
1.85
Quantity 3,760 New position
Value US$6,956
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-17 2026-11-16 B Purchase

Chief Financial Officer

Officer
76,621 +26.4%
493.90
US$4,266,852
76,621 +26.4% 493.90 US$4,266,852
2026-11-17 2026-11-16 B Purchase

Chief Financial Officer

Officer
15,117 +41.5%
389.95
US$330,609
15,117 +41.5% 389.95 US$330,609
2026-11-17 2026-11-16 B Purchase

Chief Medical Officer

Officer
56,406 +12.5%
255.00
US$3,687,813
56,406 +12.5% 255.00 US$3,687,813
2026-08-19 2026-08-18 B Purchase

Chief Financial Officer

Officer
750 +42.9%
3.27
US$2,452
750 +42.9% 3.27 US$2,452
2025-12-22 2025-12-19 B Purchase Non-Executive Director
4,200 +13.1%
0.24
US$987
4,200 +13.1% 0.24 US$987
2025-12-11 2025-12-09 B Purchase

Chief Financial Officer

Officer
14,500 +483.3%
0.35
US$5,098
14,500 +483.3% 0.35 US$5,098
2025-08-28 2025-08-27 B Purchase Non-Executive Director
10,000 +25.4%
0.86
US$8,565
10,000 +25.4% 0.86 US$8,565
2025-08-28 2025-08-26 B Purchase Non-Executive Director
25,000 +173.6%
0.89
US$22,248
25,000 +173.6% 0.89 US$22,248
2025-08-25 2025-08-22 B Purchase

Chief Medical Officer

Officer
10,000 +20.8%
0.80
US$8,000
10,000 +20.8% 0.80 US$8,000
2025-07-02 2025-06-30 B Purchase Non-Executive Director
10,000 +55.6%
0.42
US$4,174
10,000 +55.6% 0.42 US$4,174
2025-06-27 2025-06-24 B Purchase Non-Executive Director
40,000 +100.0%
0.36
US$14,396
40,000 +100.0% 0.36 US$14,396
2025-05-22 2025-05-20 B Purchase Non-Executive Director
10,000 New position
1.28
US$12,815
10,000 New position 1.28 US$12,815
2025-05-20 2025-05-20 B Purchase

Chief Medical Officer

Officer
4,500 +32.9%
1.25
US$5,625
4,500 +32.9% 1.25 US$5,625
2025-02-27 2024-12-11 B Purchase Non-Executive Director
10,000 +33.3%
2.04
US$20,405
10,000 +33.3% 2.04 US$20,405
2024-11-19 2024-11-18 B Purchase

Chief Medical Officer

Officer
4,250 +45.0%
1.99
US$8,458
4,250 +45.0% 1.99 US$8,458
2024-10-01 2024-09-30 B Purchase

Chief Medical Officer

Officer
1,000 +11.9%
4.26
US$4,258
1,000 +11.9% 4.26 US$4,258
2025-02-27 2024-08-15 B Purchase Non-Executive Director
10,000 +50.0%
5.24
US$52,396
10,000 +50.0% 5.24 US$52,396
2025-02-27 2024-06-17 B Purchase Non-Executive Director
10,000 +100.0%
4.35
US$43,521
10,000 +100.0% 4.35 US$43,521
2025-02-27 2024-06-14 B Purchase Non-Executive Director
10,000 New position
3.69
US$36,905
10,000 New position 3.69 US$36,905
2023-11-27 2023-11-22 B Purchase Non-Executive Director
100,000 +609.8%
0.40
US$40,000
100,000 +609.8% 0.40 US$40,000
2023-06-01 2023-05-30 B Purchase

Chief Medical Officer

Officer
1,150 +1.7%
0.48
US$546
1,150 +1.7% 0.48 US$546
2023-06-01 2023-05-30 B Purchase

Chief Medical Officer

Officer
2,300 +3.6%
0.48
US$1,092
2,300 +3.6% 0.48 US$1,092
2023-06-01 2023-05-30 B Purchase

Chief Medical Officer

Officer
4,000 +6.6%
0.48
US$1,920
4,000 +6.6% 0.48 US$1,920
2023-06-01 2023-05-30 B Purchase

Chief Medical Officer

Officer
5,093 +9.2%
0.47
US$2,394
5,093 +9.2% 0.47 US$2,394
2023-05-30 2023-05-25 B Purchase Non-Executive Director
20,000 +250.7%
0.50
US$10,000
20,000 +250.7% 0.50 US$10,000
2023-05-22 2023-05-18 B Purchase

Chief Medical Officer

Officer
7,500 +15.6%
0.70
US$5,248
7,500 +15.6% 0.70 US$5,248
2022-11-01 2022-10-28 B Purchase Large shareholder
200,000
0.00
US$0
200,000 0.00 US$0
2022-11-01 2022-10-28 B Purchase Large shareholder
300,000
0.00
US$0
300,000 0.00 US$0
2023-04-07 2022-04-05 B Purchase

Chief Medical Officer

Officer
3,760 New position
1.85
US$6,956
3,760 New position 1.85 US$6,956